Sign In
Buy MGNX
$4.69
+0.110 (+2.40%)
At Close: Jun 23, 2026
Mid-Morning Market Update: Markets Mixed; General Motors Beats Q1 Views
02:22pm, Wednesday, 06'th May 2020Edited Transcript of MGNX earnings conference call or presentation 5-May-20 8:30pm GMT
09:24am, Wednesday, 06'th May 2020
Q1 2020 MacroGenics Inc Earnings Call
MacroGenics' (MGNX) CEO Scott Koenig on Q1 2020 Results - Earnings Call Transcript
03:52am, Wednesday, 06'th May 2020
MacroGenics, Inc. (NASDAQ:MGNX) Q1 2020 Earnings Conference Call May 5, 2020 04:30 PM ET Company Participants Anna Krassowska - VP, IR and Corporate Communicati
MacroGenics Analyst Sees Multiple Sources Of Upside, Biopharma Rallies After Q1 Update
12:00am, Wednesday, 06'th May 2020
MacroGenics Inc (NASDAQ: MGNX) reported Tuesday after the close with forecast-beating first-quarter results and said it has adequate cash to operate into 2022. The company...
MacroGenics (MGNX) Reports Q1 Loss, Tops Revenue Estimates
10:45pm, Tuesday, 05'th May 2020
MacroGenics (MGNX) delivered earnings and revenue surprises of 9.90% and 84.12%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
MacroGenics Provides Update on Corporate Progress and First Quarter 2020 Financial Results
08:01pm, Tuesday, 05'th May 2020
ROCKVILLE, Md., May 05, 2020 -- MacroGenics, Inc. (NASDAQ: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal.
Trump Pushes for US-Made Medical Products: 4 Winners
12:36pm, Tuesday, 05'th May 2020
An executive order to address the lack of medical product manufacturing in the United States could in a way boost manufacturing and sales of home-grown goods.
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech stocks hitting 52-week highs May 5.)
Arcturus Therapeutics Ltd (...
The Week Ahead In Biotech: Smid-Cap Earnings News Flow Picks Up Pace
12:00am, Sunday, 03'rd May 2020
Biotech stocks started last week on a strong note but the upward momentum slowed through the week. The week saw a slew of earnings from big pharma names, including Merck...
Agios' (AGIO) Q1 Loss Narrower Than Expected, Revenues Beat
01:57pm, Friday, 01'st May 2020
Agios' (AGIO) loss and revenues better estimates in Q1. The company's wholly owned leukemia drug Tibsovo sees a sequential rise in sales.
Bank of America Corp DE Trims Position in MacroGenics Inc (NASDAQ:MGNX)
09:17am, Friday, 01'st May 2020
Bank of America Corp DE lessened its stake in shares of MacroGenics Inc (NASDAQ:MGNX) by 16.7% during the 4th quarter, Holdings Channel reports. The fund owned 34,306 shares of the biopharmaceutical c
MacroGenics Announces Presentations at the 2020 ASCO Annual Meeting
08:01pm, Wednesday, 29'th Apr 2020
Rockville, MD, April 29, 2020 -- MacroGenics, Inc. (NASDAQ: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal.
MacroGenics to Host its Annual Meeting of Stockholders in Virtual Format
08:01pm, Tuesday, 28'th Apr 2020
MacroGenics, Inc. (MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment of cancer, today announce
Easy Come, Easy Go: How MacroGenics (NASDAQ:MGNX) Shareholders Got Unlucky And Saw 72% Of Their Cash Evaporate
12:48pm, Tuesday, 28'th Apr 2020
MacroGenics, Inc. (NASDAQ:MGNX) shareholders will doubtless be very grateful to see the share price up 30% in the last...
MacroGenics Announces Date of First Quarter 2020 Financial Results Conference Call
11:30am, Tuesday, 28'th Apr 2020
MacroGenics, Inc. (MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment of cancer, today announce
